thiotepa has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, ST | 1 |
| Schulz, G | 1 |
| Hente, M | 1 |
| Slater, A | 1 |
| Murray, L | 1 |
| Shenoy, S | 1 |
| Bednarski, JJ | 1 |
| Kapoor, R | 1 |
| Rastogi, N | 1 |
| Yadav, SP | 1 |
| Lindsey, JK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Immune Function Disorders Using a Reduced Intensity Preparatory Regime[NCT01821781] | Phase 2 | 20 participants (Anticipated) | Interventional | 2013-03-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for thiotepa and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease.
Topics: Alemtuzumab; Child; Child, Preschool; Follow-Up Studies; Graft vs Host Disease; Granulomatous Diseas | 2020 |
2 other studies available for thiotepa and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
Haploidentical Stem Cell Transplant With Post Transplant Cyclophosphamide for Chronic Granulomatous Disease With Thiotepa, Busulfan, and Fludarabine as Conditioning.
Topics: Antineoplastic Agents; Busulfan; Child, Preschool; Cyclophosphamide; Granulomatous Disease, Chronic; | 2021 |
A general family of distributions for longitudinal dependence with special reference to event histories.
Topics: Antineoplastic Agents, Alkylating; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Longitu | 2001 |